Maturitas
Volume 55, Issue 1 , Pages 1-4, 20 August 2006

Updating the EMAS 2004/2005 clinical recommendations on postmenopausal therapy following the recent publications: WHI and Nurses’ Health Study

Frederiksberg Hospital, Department of Ob/Gyn, 2000 Frederiksberg F, Denmark

Received 27 March 2006; accepted 27 March 2006.

Abstract 

This new statement from EMAS presents the findings reported in recent publications from both WHI and the Nurses’ Health Study to consider if these findings require the EMAS position to be modified. In general the reports do not necessitate a revision of the current EMAS advice but do provide further insight into the ongoing controversy around the possibility that estrogen (E) or estrogen–progestogen (E–P) use in younger postmenopausal women may supply cardiovascular benefit in the younger group.

Keywords: EMAS, Clinical recommendations, ET, EPT, Coronary heart disease, WHI, NHS

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(06)00102-2

doi:10.1016/j.maturitas.2006.03.011

Maturitas
Volume 55, Issue 1 , Pages 1-4, 20 August 2006

Article Tools